COPD Archives - Express Pharma

AstraZeneca’s AZD6793 holds potential to expand oral COPD treatment options, says GlobalData

Zydus launches REVAHALE, India’s first once-daily nebulised LAMA for COPD

AstraZeneca strengthens COPD treatment pathways

Real-world data backs anti-IL-5 use in COPD with comorbid asthma

Lupin collaborates with Honeywell, plans for HFO technology in Inhalers

GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients: GlobalData

COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData

EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD: GlobalData

AstraZeneca receives CDSCO approval to market its inhalation aerosol

Lupin partners with Cost Plus Drugs, COPD Foundation